Home > News > Prospectus Documents > Acacia Pharma Summary: Issues of New Ordinary Shares in connection with the BYFAVO™ Acquisition

Press Releases

24 March 2020

Acacia Pharma Summary: Issues of New Ordinary Shares in connection with the BYFAVO™ Acquisition

Acacia Pharma Summary: Issues of New Ordinary Shares in connection with the BYFAVO™ Acquisition

Download PDF

< back to list